Avita Therapeutics Inc
Cerrado
3.92 -1.26
Resumen
Variación precio
24h
Mínimo
3.88
Máximo
3.95
Ingresos | 1M -11M |
|---|---|
Ventas | 1.6M 19M |
BPA | -0.48 |
Margen de beneficios | -55.119 |
Empleados | 226 |
EBITDA | 1.1M -8.6M |
Recomendaciones | Compra Fuerte |
|---|---|
Estimación a 12 Meses | +83.38% upside |
Próximas Ganancias | 6 ago 2026 |
|---|
Capitalización Mercado | -5.8M 129M |
|---|---|
Apertura anterior | 5.18 |
Cierre anterior | 3.92 |
Avita Therapeutics Inc Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Acerca de Avita Therapeutics Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.